Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
5 hedge funds and large institutions have $1.57M invested in Synergy Pharmaceuticals, Inc. - Warrants in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
161% more capital invested
Capital invested by funds: $600K → $1.57M (+$968K)
150% more funds holding
Funds holding: 2 → 5 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$575K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$1.01K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$66 |
Top Sellers
SGYPW Hedge Fund Activity: Q4 2013 in Review
5 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q4 2013, worth a combined $1.57M — up 161% from $600K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SGYPW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $575K.
- 5 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q4 2013, up from 2 in Q3 2013.
- Funds reported $1.57M of Synergy Pharmaceuticals, Inc. - Warrants stock for Q4 2013, up 161% quarter-over-quarter.
- 3 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q4 2013 and 0 closed out, a net change of +3 holders.
- The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q4 2013 was Sabby Management, an estimated $575K added.
Based on aggregated 13F filings for Q4 2013.